This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Serruys, P. W. Articles by van der Giessen, W. J. Search for Related Content PubMed PubMed Citation Articles by Serruys, P. W. Articles by van der Giessen, W. J.

CLINICAL RESEARCH

Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment

Results of a randomized trial: Beta-radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE)

Patrick W. Serruys, MD, PhD, FACC^*,*, William Wijns, MD, Georgios Sianos, MD, PhD^*, Ivan de Scheerder, MD, Paul A. van den Heuvel, MD, Wolfgang Rutsch, MD^||, Helmut D. Glogar, MD^¶, Carlos Macaya, MD^#, Pierre H. Materne, MD^**, Susan Veldhof, RN, Heike Vonhausen, PhD, Patricia C. Otto-Terlouw, MSc and Wim J. van der Giessen, MD, PhD^*

^* Erasmus Medical Center, Rotterdam, The Netherlands
Onze Lieve Vrouw Ziekenhuis, Aalst, Belgium
UZ Gasthuisberg, Leuven, Belgium
Academisch Ziekenhuis Middelheim, Antwerpen, Belgium
^|| Universitätsklinik Charité, Berlin, Germany
^¶ Allgemeines Krankenhaus der Stadt, Wien, Austria
^# Hospital Clínico San Carlos, Madrid, Spain
^** CHR de la Citadelle, Liege, Belgium
Guidant, Diegem, Belgium
Cardialysis BV, Rotterdam, The Netherlands

Manuscript received November 21, 2003; revised manuscript received March 1, 2004, accepted March 2, 2004.

^* Reprint requests and correspondence: Professor Patrick W. Serruys, Erasmus Medical Center, Thoraxcenter, Bd-406, Dr. Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
p.w.j.c.serruys{at}erasmusmc.nl

OBJECTIVES: We sought to assess the efficacy of vascular brachytherapy (VBT) combined with stenting for the primary prevention of restenosis.

BACKGROUND: Intravascular brachytherapy after stent implantation for de novo lesions has been abandoned for the present. We revisited this procedure by optimizing all procedural steps—the use of glycoprotein IIb/IIIa blockers, direct stenting, adequate radiation coverage, avoidance of edge damage, source centering, intravascular ultrasound-guided dosimetry, and continuation of a dual anti-platelet regimen for one year.

METHODS: The Beta-Radiation Investigation with Direct stenting and Galileo in Europe (BRIDGE) study is a multicenter, randomized controlled trial evaluating the long-term efficacy of VBT with P-32 (20 Gy at 1 mm in the coronary wall) after direct stenting. The primary end point was angiographic intra-stent late loss; secondary end points were six months binary restenosis and neo-intimal hyperplasia. Patients (n = 112) with de novo lesions (2.5 to 4.0 mm in diameter up to 15 mm long) were randomized to either VBT or no-VBT.

RESULTS: At six months, intra-stent loss was 0.43 and 0.84 mm (p < 0.001) in the irradiated and control groups, respectively. Intra-stent neo-intimal volume was reduced from 36 mm³ to 10 mm³. However, in the irradiated group there were six late occlusions as well as eight restenoses outside the stented and peri-stented area at the fall-off dose edges of the irradiated area. Accordingly, the target vessel revascularization and major adverse cardiac and cerebrovascular events rates at one year in the VBT group (20.4% and 25.9%, respectively) were higher than in the control group (12.1% and 17.2%, respectively).

CONCLUSIONS: Despite the optimization of pre-, peri-, and post-procedural factors and despite the relative efficacy of the brachytherapy for the prevention of the intra-stent neo-intimal hyperplasia, the clinical outcome of the irradiated group was less favorable than that of the control group.

Abbreviations and Acronyms   EIRS = effective irradiated segment   GM = geographical miss   IVUS = intravascular ultrasound   MACCE = major adverse cardiac and cerebrovascular events   MI = myocardial infarction   MLD = minimal luminal diameter   QCA = quantitative coronary angiography   VBT = vascular brachytherapy

This article has been cited by other articles:

				J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text]

				E. Camenzind, P. G. Steg, and W. Wijns A Cause for Concern Circulation, March 20, 2007; 115(11): 1440 - 1455. [Full Text] [PDF]

				J. C.J. Sun, J. W. Eikelboom, P. Agostoni, G. M. Sangiorgi, G. G. Biondi-Zoccai, B. Scheller, M. Bohm, and E. Camenzind Treatment of Restenosis with a Paclitaxel-Coated Balloon Catheter N. Engl. J. Med., March 8, 2007; 356(10): 1071 - 1073. [Full Text] [PDF]

				W. W. O'Neill, S. R. Dixon, and C. L. Grines The year in interventional cardiology J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1117 - 1134. [Full Text] [PDF]

				REFERENCES J. ICRU, December 1, 2004; 4(2): 165 - 175. [Full Text] [PDF]